European Union · Record · CJ
CELEX 62000CJ0143
Judgment of the Court of 23 April 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd and Eli Lilly and Co. v Swingward Ltd and Dowelhurst Ltd.#Reference for a preliminary ruling: High Court of Justice (England & Wales), Chancery Division - United Kingdom.#Trade marks - Directive 89/104/EEC - Article 7(2) - Exhaustion of the rights conferred by the trade mark - Pharmaceutical products - Parallel importation - Repackaging of the trade-marked product.#Case C-143/00.
Introduced
23 April 2002
Last action
—
Status
decided
Sponsors
—
Subjects
Discovery layer
Source updated
23 April 2002
Records
Official record CELEX 62000CJ0143 from European Union at Court of Justice of the European Union. Dated 23 April 2002. Status: decided.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
23 official files
Judgment of the Court of 23 April 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd and Eli Lilly and Co. v Swingward Ltd and Dowelhurst Ltd.#Reference for a preliminary ruling: High Court of Justice (England & Wales), Chancery Division - United Kingdom.#Trade marks - Directive 89/104/EEC - Article 7(2) - Exhaustion of the rights conferred by the trade mark - Pharmaceutical products - Parallel importation - Repackaging of the trade-marked product.#Case C-143/00.
judgment · EN · 23 April 2002
Решение на Съда от 23 април 2002 г.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd и Eli Lilly and Co. срещу Swingward Ltd и Dowelhurst Ltd.#Искане за преюдициално заключение: High Court of Justice (England & Wales), Chancery Division - Обединеното кралство.#Директива 89/104/ЕИО.#Дело C-143/00.
judgment · BG · 23 April 2002
Presuda Suda od 23. travnja 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd i Eli Lilly and Co. protiv Swingward Ltd i Dowelhurst Ltd.#Zahtjev za prethodnu odluku: High Court of Justice (England & Wales), Chancery Division - Ujedinjena Kraljevina.#Direktiva 89/104/EEZ.#Predmet C-143/00.
judgment · HR · 23 April 2002
Rozsudok Súdneho dvora z 23. apríla 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd a Eli Lilly and Co. proti Swingward Ltd a Dowelhurst Ltd.#Návrh na začatie prejudiciálneho konania High Court of Justice (England & Wales), Chancery Division - Spojené kráľovstvo.#Vec C-143/00.
judgment · SK · 23 April 2002
Sentenza tal-Qorti tal-Ġustizzja tat-23 ta' April 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd u Eli Lilly and Co. vs Swingward Ltd u Dowelhurst Ltd.#Talba għal deċiżjoni preliminari: High Court of Justice (England & Wales), Chancery Division - ir-Renju Unit.#Direttiva 89/104/KEE.#Kawża C-143/00.
judgment · MT · 23 April 2002
Hotărârea Curții din data de 23 aprilie 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd și Eli Lilly and Co. împotriva Swingward Ltd și Dowelhurst Ltd.#Cerere având ca obiect pronunțarea unei hotărâri preliminare: High Court of Justice (England & Wales), Chancery Division - Regatul Unit.#Directivă 89/104/CEE.#Cauza C-143/00.
judgment · RO · 23 April 2002
Sodba Sodišča z dne 23. aprila 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd in Eli Lilly and Co. proti Swingward Ltd in Dowelhurst Ltd.#Predlog za sprejetje predhodne odločbe: High Court of Justice (England & Wales), Chancery Division - Združeno kraljestvo.#Zadeva C-143/00.
judgment · SL · 23 April 2002
Rozsudek Soudního dvora ze dne 23. dubna 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd a Eli Lilly and Co. proti Swingward Ltd a Dowelhurst Ltd.#Žádost o rozhodnutí o předběžné otázce: High Court of Justice (England & Wales), Chancery Division - Spojené království.#Věc C-143/00.
judgment · CS · 23 April 2002
Euroopa Kohtu otsus, 23. aprill 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd ja Eli Lilly and Co. versus Swingward Ltd ja Dowelhurst Ltd.#Eelotsusetaotlus: High Court of Justice (England & Wales), Chancery Division - Ühendkuningriik.#Direktiiv 89/104/EMÜ.#Kohtuasi C-143/00.
judgment · ET · 23 April 2002
Tiesas spriedums 2002. gada 23.aprīlī.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd un Eli Lilly and Co. pret Swingward Ltd un Dowelhurst Ltd.#Lūgums sniegt prejudiciālu nolēmumu: High Court of Justice (England & Wales), Chancery Division - Apvienotā Karaliste.#Direktīva 89/104/EEK.#Lieta C-143/00.
judgment · LV · 23 April 2002
Arrêt de la Cour du 23 avril 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd et Eli Lilly and Co. contre Swingward Ltd et Dowelhurst Ltd.#Demande de décision préjudicielle: High Court of Justice (England & Wales), Chancery Division - Royaume-Uni.#Marques - Directive 89/104/CEE - Article 7, paragraphe 2 - Epuisement du droit conféré par la marque - Médicaments - Importation parallèle - Reconditionnement du produit revêtu de la marque.#Affaire C-143/00.
judgment · FR · 23 April 2002
Sentenza della Corte del 23 aprile 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd e Eli Lilly and Co. contro Swingward Ltd e Dowelhurst Ltd.#Domanda di pronuncia pregiudiziale: High Court of Justice (England & Wales), Chancery Division - Regno Unito.#Marchi - Direttiva 89/104/CEE - Art. 7, n. 2 - Esaurimento del diritto conferito dal marchio - Medicinali - Importazione parallela - Riconfezionamento del prodotto munito del marchio.#Causa C-143/00.
judgment · IT · 23 April 2002
Acórdão do Tribunal de 23 de Abril de 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd e Eli Lilly and Co. contra Swingward Ltd e Dowelhurst Ltd.#Pedido de decisão prejudicial: High Court of Justice (England & Wales), Chancery Division - Reino Unido.#Marcas - Directiva 89/104/CEE - Artigo 7.º, n.º 2 - Esgotamento do direito conferido pela marca - Medicamentos - Importação paralela - Reacondicionamento do produto portador da marca.#Processo C-143/00.
judgment · PT · 23 April 2002
A Bíróság április 23.-i ítélete: 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd és Eli Lilly and Co. kontra Swingward Ltd és Dowelhurst Ltd.#Előzetes döntéshozatal iránti kérelem: High Court of Justice (England & Wales), Chancery Division - Egyesült Királyság.#89/104/EGK irányelv.#C-143/00. sz. ügy.
judgment · HU · 23 April 2002
2002 m. balanžio 23 d. Teisingumo Teismo sprendimas.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd ir Eli Lilly and Co. prieš Swingward Ltd ir Dowelhurst Ltd.#Prašymas priimti prejudicinį sprendimą: High Court of Justice (England & Wales), Chancery Division - Jungtinė Karalystė.#Direktyva 89/104/EEB.#Byla C-143/00.
judgment · LT · 23 April 2002
Domstolens dom den 23 april 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd och Eli Lilly and Co. mot Swingward Ltd och Dowelhurst Ltd.#Begäran om förhandsavgörande: High Court of Justice (England & Wales), Chancery Division - Förenade kungariket.#Varumärken - Direktiv 89/104/EEG - Artikel 7.2 - Konsumtion av de rättigheter som är knutna till ett varumärke - Läkemedel - Parallellimport - Ompaketering av en vara som är försedd med varumärket.#Mål C-143/00.
judgment · SV · 23 April 2002
Urteil des Gerichtshofes vom 23. April 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd und Eli Lilly and Co. gegen Swingward Ltd und Dowelhurst Ltd.#Ersuchen um Vorabentscheidung: High Court of Justice (England & Wales), Chancery Division - Vereinigtes Königreich.#Marken - Richtlinie 89/104/EWG - Artikel 7 Absatz 2 - Erschöpfung des Rechts aus der Marke - Arzneimittel - Paralleleinfuhr - Umpacken der mit der Marke versehenen Ware.#Rechtssache C-143/00.
judgment · DE · 23 April 2002
Domstolens Dom af 23. april 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd og Eli Lilly and Co. mod Swingward Ltd og Dowelhurst Ltd.#Anmodning om præjudiciel afgørelse: High Court of Justice (England & Wales), Chancery Division - Forenede Kongerige.#Varemærker - direktiv 89/104/EØF - artikel 7, stk. 2 - konsumption af de til varemærket knyttede rettigheder - lægemidler - parallelimport - ompakning af varer, der er forsynet med varemærket.#Sag C-143/00.
judgment · DA · 23 April 2002
Wyrok Trybunału z dnia 23 kwietnia 2002 r.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd i Eli Lilly and Co. przeciwko Swingward Ltd i Dowelhurst Ltd.#Wniosek o wydanie orzeczenia w trybie prejudycjalnym: High Court of Justice (England & Wales), Chancery Division - Zjednoczone Królestwo.#Dyrektywa 89/104/EWG.#Sprawa C-143/00.
judgment · PL · 23 April 2002
Sentencia del Tribunal de Justicia de 23 de abril de 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd y Eli Lilly and Co. contra Swingward Ltd y Dowelhurst Ltd.#Petición de decisión prejudicial: High Court of Justice (England & Wales), Chancery Division - Reino Unido.#Marcas - Directiva 89/104/CEE - Artículo 7, apartado 2 - Agotamiento del derecho conferido por la marca - Medicamentos - Importación paralela - Reenvasado del producto con la marca.#Asunto C-143/00.
judgment · ES · 23 April 2002
Yhteisöjen tuomioistuimen tuomio 23 päivänä huhtikuuta 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd ja Eli Lilly and Co. vastaan Swingward Ltd ja Dowelhurst Ltd.#Ennakkoratkaisupyyntö: High Court of Justice (England & Wales), Chancery Division - Yhdistynyt kuningaskunta.#Tavaramerkit - Direktiivi 89/104/ETY - Direktiivin 89/104/ETY 7 artiklan 2 kohta - Tavaramerkkioikeuden sammuminen - Lääkkeet - Rinnakkaistuonti - Tavaramerkillä varustettujen tuotteiden uudelleen pakkaaminen.#Asia C-143/00.
judgment · FI · 23 April 2002
Απόφαση του Δικαστηρίου της 23ης Απριλίου 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd και Eli Lilly and Co. κατά Swingward Ltd και Dowelhurst Ltd.#Αίτηση για την έκδοση προδικαστικής αποφάσεως: High Court of Justice (England & Wales), Chancery Division - Ηνωμένο Βασίλειο.#Σήματα - Οδηγία 89/104/ΕΟΚ - Άρθρο 7, παράγραφος 2 - Ανάλωση του δικαιώματος που παρέχει το σήμα - Φάρμακα - Παράλληλη εισαγωγή - Ανασυσκευασία του προϊόντος που φέρει το σήμα.#Υπόθεση C-143/00.
judgment · EL · 23 April 2002
Arrest van het Hof van 23 april 2002.#Boehringer Ingelheim KG, Boehringer Ingelheim Pharma KG, Glaxo Group Ltd, The Wellcome Foundation Ltd, SmithKline Beecham plc, Beecham Group plc, SmithKline & French Laboratories Ltd en Eli Lilly and Co. tegen Swingward Ltd en Dowelhurst Ltd.#Verzoek om een prejudiciële beslissing: High Court of Justice (England & Wales), Chancery Division - Verenigd Koninkrijk.#Merken - Richtlijn 89/104/EEG - Artikel 7, lid 2 - Uitputting van aan merk verbonden recht - Geneesmiddelen - Parallelimport - Ompakking van merkproduct.#Zaak C-143/00.
judgment · NL · 23 April 2002
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.